Your browser doesn't support javascript.
loading
COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection.
Kotfis, Katarzyna; Lechowicz, Kacper; Drozdzal, Sylwester; Niedzwiedzka-Rystwej, Paulina; Wojdacz, Tomasz K; Grywalska, Ewelina; Biernawska, Jowita; Wisniewska, Magda; Parczewski, Milosz.
Afiliação
  • Kotfis K; Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
  • Lechowicz K; Department of Anesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.
  • Drozdzal S; Department of Pharmacokinetics and Monitored Therapy, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Niedzwiedzka-Rystwej P; Institute of Biology, University of Szczecin, 71-412 Szczecin, Poland.
  • Wojdacz TK; Independent Clinical Epigenetics Laboratory, Pomeranian Medical University, 71-252 Szczecin, Poland.
  • Grywalska E; Department of Clinical Immunology and Immunotherapy, Medical University of Lublin, 20-093 Lublin, Poland.
  • Biernawska J; Department of Anesthesiology and Intensive Therapy, Pomeranian Medical University in Szczecin, 71-252 Szczecin, Poland.
  • Wisniewska M; Clinical Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, 70-111 Szczecin, Poland.
  • Parczewski M; Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, 71-455 Szczecin, Poland.
Pharmaceuticals (Basel) ; 14(1)2021 Jan 17.
Article em En | MEDLINE | ID: mdl-33477294
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article